title: Intravenous starches: is suspension the best solution?
authors.affiliation: From the Department of Anesthesiology, Duke University Medical Center; and Durham VAMC, Durham, North Carolina.
authors.forename: Karthik
authors.initials: K
authors.lastname: Raghunathan
authors.forename: Timothy E
authors.initials: TE
authors.lastname: Miller
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Shaw
mesh_terms: D003422:Critical Care / Q000379:methods; D000077324:Crystalloid Solutions; D019317:Evidence-Based Medicine; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D007275:Injections, Intravenous; D007552:Isotonic Solutions / Q000009:adverse effects / Q000627:therapeutic use; D019990:Perioperative Care; D010952:Plasma Substitutes / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013535:Suspensions
chemical_list: D000077324:Crystalloid Solutions; D006895:Hydroxyethyl Starch Derivatives; D007552:Isotonic Solutions; D010952:Plasma Substitutes; D013535:Suspensions